Act Biotech Inc entered the industry of Commercial Biotechnical Research in 2008 and has grown to employ 1 to 4 people, generating an annual revenue of $500.000 to $999.999. The NAICS classifies this business under the code 541711, which describes it as a Commercial Biotechnical Research. For further clarification, the SIC classifies this business under the code 8731 and described it as a Commercial Biotechnical Research. The business provides service to the B2B market.
To acquire more information, please contact Tisa Beene by calling (415) 230-3901 during business hours. You can also write to the business’ Single Location at 717 Market St # 650, San Francisco, California CA 94103. You can also visit the company’s website at actbiotech.com. View this business’ social media profiles on Twitter or on Facebbok .
Company: | Act Biotech Inc |
Representative: | Tisa Beene |
Place of Business: | 717 Market St # 650, San Francisco, CA 94103 |
Contact Number: | (415) 230-3901 |
Website: | actbiotech.com |
Type of Service: | Commercial Biotechnical Research |
SIC Number: | 8731 |
NAICS Number: | 541711 |
Locality: | Single Location |
Market Type: | B2B (Business to Business) |
Began: | 2008 |
Income/Year: | $500.000 to $999.999 |
Laborers: | 1 to 4 |
Share This Company: |
Act Biotech Inc is a company operating from San Francisco, California providing professional Commercial Biotechnical Research and relevant B2B variables. It was founded in 2008 and registered with the SIC code 8731 as Commercial Biotechnical Research, and with the NAICS code 541711 as Commercial Biotechnical Research.
With a current employee count of 1 to 4, Act Biotech Inc has gone to report making $500.000 to $999.999 per annum on its journey towards growth. This company invites you to contact its representative Tisa Beene at (415) 230-3901 for related queries, or to locate its Single Location using the coordinates .
The Single Location can also be found at the street address 717 Market St # 650 in San Francisco, California 94103 and can be engaged online through the company website at actbiotech.com, the company Twitter , and Facebook page .